Work

Expanding criteria for prognostic stage IA disease in HR+ breast cancer.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.550

Authors: Olga Kantor, Tari A. King, Steven Shak, Christy Ann Russell, Armando E. Giuliano, Gabriel N. Hortobagyi, Harold J. Burstein, Eric P. Winer, Joseph A. Sparano, Elizabeth A. Mittendorf

Institutions: Dana-Farber Brigham Cancer Center, Genomic Health (United States), University of Southern California, USC Norris Comprehensive Cancer Center, Cedars-Sinai Medical Center, The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute, Harvard University, Dana-Farber/Harvard Cancer Center, Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Brigham and Women's Hospital

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3030412260

Cites:

Cited by:

Related to: 10